Nanalysis Scientific Corp. (CVE:NSCI – Get Free Report)’s stock price reached a new 52-week low on Tuesday . The company traded as low as C$0.11 and last traded at C$0.12, with a volume of 10600 shares changing hands. The stock had previously closed at C$0.12.
Nanalysis Scientific Stock Performance
The business’s 50-day moving average price is C$0.14 and its 200-day moving average price is C$0.15. The company has a current ratio of 1.42, a quick ratio of 1.10 and a debt-to-equity ratio of 71.72. The stock has a market cap of C$19.11 million, a PE ratio of -2.76 and a beta of -0.52.
Nanalysis Scientific Company Profile
Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries.
Featured Articles
- Five stocks we like better than Nanalysis Scientific
- 2 Space and Defense Stocks Turning Backlogs Into Revenue Growth
- Energy Fuels Just Made a Bold Bet on Rare Earth Magnets
- Washington’s Quantum Push Puts IBM and IonQ on the Throne
- FedEx’s Earnings Drop May Be Missing the Bigger Freight Story
Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
